Laura Stoppel
InvestorPartner at RA Capital
Somerville, Massachusetts
Writes $100K β $5M checks Β· typically $100K
Experience
- RA Capital ManagementPartnercurrent2024 β present
- RA Capital ManagementPrincipal2020 β 2024
- RA Capital ManagementAnalyst2020
- RA Capital ManagementSenior Associate2018 β 2020
- RA Capital ManagementAssociate2016 β 2018
- Infinant HealthBoard Membercurrent2026 β present
- Verdiva BioBoard Membercurrent2024 β present
- CellCentricBoard Membercurrent2024 β present
- International Rett Syndrome FoundationBoard Membercurrent2023 β present
- Artiva BiotherapeuticsBoard Membercurrent2020 β present
- Nimbus TherapeuticsBoard Membercurrent2020 β present
- Acumen Pharmaceuticals, Inc.Board Membercurrent2020 β present
Education
- Massachusetts Institute of TechnologyDoctor of Philosophy (PhD), Neuroscience2011 β 2016
- Harvard UniversityBA, Biology2004 β 2008
Skills & more
MatlabPublic SpeakingNeuroscienceTeachingResearchMolecular BiologyConfocal MicroscopyFluorescence MicroscopyHigher EducationCell CultureCell BiologyData Analysis
+5 more
ImmunohistochemistryMicroscopyScienceStatisticsWestern BlottingFrom Laura's professional profile.
Same school
Also attended Massachusetts Institute of Technology989
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 983 more
Also attended Harvard University1,254
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,248 more
Shared employers
Also worked at Infinant Health2
Also worked at Verdiva Bio2
Also worked at Artiva Biotherapeutics1
Also worked at Nimbus Therapeutics6
Deals Β· 2
Artiva BiotherapeuticsBoard seat
via RA Capital Β· filed Jul 2020 Β· $78.4M raise
ContralineQuoted
via RA Capital Β· filed May 2026
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at RA Capital
Network1
Investors connected to Laura in public investor directories β a warm-intro map.























